The Effects of Oral Curcumin and Bioperine Supplementation on C - reactive protein In CrossFit Athletes by Franzen, Bailey et al.
Loma Linda University
TheScholarsRepository@LLU: Digital Archive of Research,
Scholarship & Creative Works
Loma Linda University Research Reports
2017
The Effects of Oral Curcumin and Bioperine
Supplementation on C - reactive protein In
CrossFit Athletes
Bailey Franzen
Cassandra Greenawalt
Sloan Vlahos
Follow this and additional works at: http://scholarsrepository.llu.edu/rr
Part of the Dietetics and Clinical Nutrition Commons, and the Sports Sciences Commons
This Research Report is brought to you for free and open access by TheScholarsRepository@LLU: Digital Archive of Research, Scholarship & Creative
Works. It has been accepted for inclusion in Loma Linda University Research Reports by an authorized administrator of
TheScholarsRepository@LLU: Digital Archive of Research, Scholarship & Creative Works. For more information, please contact
scholarsrepository@llu.edu.
Recommended Citation
Franzen, Bailey; Greenawalt, Cassandra; and Vlahos, Sloan, "The Effects of Oral Curcumin and Bioperine Supplementation on C -
reactive protein In CrossFit Athletes" (2017). Loma Linda University Research Reports. 1.
http://scholarsrepository.llu.edu/rr/1
 
The Effects of Oral Curcumin and Bioperine Supplementation on C - reactive protein In   
CrossFit Athletes 
 
 
 
Bailey Franzen, Cassandra Greenawalt & Sloan Vlahos 
Cory Sheen, Phd, RDN, assistant professor 
Jeje Noval, MS, RD, assistant professor 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PURPOSE. C-reactive protein (CRP) is an acute-phase inflammatory marker which circulates in 
blood plasma and rises in the presence of systemic inflammation. Strenuous exercise, such as 
that performed by CrossFit athletes, has been found to acutely raise CRP levels. Curcumin has 
demonstrated the ability to reduce CRP levels by blunting the release of pro-inflammatory 
cytokines secondary to the suppression of the NF- κB pathway. Concomitant graduate research 
administration of bioperine with curcumin improves bioavailability by 2,000%. The aim of this 
study was to evaluate the effects of oral curcumin and bioperine supplementation on CRP levels 
in CrossFit athletes.  
 
METHODS. Sixteen CrossFit athletes (Male 56.3%, Female 43.8%) provided pre-intervention 
CRP samples through a finger stick blood draw. Participants were given a combined curcumin 
(2g) and bioperine (20μg) supplement to be administered with their first meal of the day 
following 28 days after initial CRP testing. Participants were instructed to continue their usual 
exercise, dietary, and lifestyle practices over the duration of the study. On the 28th day of 
supplementation, participants provided a final CRP blood sample. Pre- and post-intervention 
CRP samples were evaluated using a paired t-test.  
 
RESULTS. Curcumin and bioperine supplementation resulted in a mean decrease in CRP levels 
of 0.26 ± 2.27 mg/L; however, this reduction failed to reach statistical significance (p = .65). 
Overall, five participants (31.3%) showed an increase in CRP at follow-up, five participants 
(31.3%) showed a decrease in CRP, and six participants (37.5%) showed no observable changes 
in CRP at follow-up, likely due to CRP levels below the testing sensitivity threshold.  
 
CONCLUSION. The majority of CrossFit athletes evaluated in this study had clinically low or 
below sensitivity threshold levels of CRP. A lack of measurable data from six participants with 
CRP levels below testing sensitivity threshold reduced the statistical power of our study. CRP 
levels in CrossFit athletes should be studied further using larger sample sizes and more sensitive 
testing devices given the apparent low CRP levels in this population. 
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Fifty percent of an individual’s overall health and longevity is associated with health-related 
behaviors.1 In addition to a healthy diet and the avoidance of tobacco, physical activity serves as 
a key practice for maintaining an overall healthy lifestyle. Due to its importance, any hindrance of 
physical activity may be detrimental to one’s health. One of the most common causes of exercise 
restriction is exercise-induced inflammation.2-4 The inflammation caused by physical activity is 
most commonly identified as either exercise-induced muscle damage (EIMD) or delayed onset 
muscle soreness (DOMS). Both EIMD and DOMS can impact subsequent training sessions and 
activities of daily living, even in regularly active individuals such as CrossFit athletes.4 With the 
purpose of helping individuals properly recover from exercise, researchers strive to determine 
ways in which EIMD and DOMS can be alleviated and prevented. 
Several studies have supported a role for nutritional intervention to maintain immune 
function in the post-exercise period.5-9 Turmeric, a bright yellow spice that comes from the root 
of the Curcuma longa plant and that is commonly used in Asian cooking, has been identified as a 
potential remedy for inflammation caused by exercise.10-12 Although turmeric has been used for 
nearly 4,000 years in southern Asia, its popularity has drastically increased over recent years in 
the United States.13 The primary component of turmeric that has been studied is the constituent 
known as curcumin. Many studies have observed a significant decrease in inflammation in those 
consuming curcumin versus those receiving a placebo.14-16 Though curcumin has shown promise 
as an anti-inflammatory agent, its bioavailability is poor and requires novel methods of delivery 
to achieve therapeutic effects.17 Bioperine, also referred to as piperine, is a major constituent of 
black pepper and is known to inhibit hepatic and intestinal glucuronidation. Previous studies 
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found that administering 20 μg of bioperine produced significantly higher serum concentrations, 
increasing curcumin bioavailability by 2,000% after only 45 minutes.17 Additionally, it has been 
shown that concomitant administration of 20 μg of bioperine produced much higher serum 
concentrations from 15 minutes to 1-hour post administration; the increase in bioavailability was 
2,000%.18 The mechanism for increased bioavailability is that bioperine binds to multiple sights 
of the CYP3A4 enzyme in cytochrome P450 and intercalates with curcumin to form a hydrogen 
bonded complex, thereby inhibiting enzymes that cause glucuronosylation of curcumin.19  
C-reactive protein (CRP) is a protein found in blood plasma; CRP levels rise in response 
to inflammation. Given the substantial evidence of curcumin’s role in suppressing inflammatory 
markers, there is valid reason to believe that oral curcumin and bioperine supplementation may 
aid in the reduction of CRP levels. Thus far, research has primarily focused on curcumin’s 
impact on circulating cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor alpha 
(TNF-), in the post-exercise period.16,20-27 
CrossFit athletes regularly partake in varied functional movements performed at 
relatively high intensity. Such movements reflect, but are not limited to, aspects of gymnastics, 
weightlifting, running, and rowing. Exercise is an important stressor to the body, leading to an 
activation of immune responses commonly evoked by other stressors such as trauma and sepsis. 
This has been verified by elevated levels of serum CRP immediately following high-intensity 
exercise in healthy adult males.28 To date, there are no definitive answers as to whether acute 
exercise related inflammatory markers may have a negative effect over the long term. Some 
research has demonstrated a reduction in markers, such as CRP, after prolonged exposure to 
routine exercise, while other studies have shown no such reduction. This variation in results is 
likely due to concomitant factors such as healthier dietary patterns or weight reduction 
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commonly found in conjunction with routine exercise; both factors are known to reduce markers 
of inflammation.29 This hypothesis was supported by the Inflammation and Exercise 
(INFLAME) study, which concluded that exercise without weight loss does not result in the 
reduction of CRP.30 CRP is a systemic marker of negative health effects, such as increased risks 
for various cancers, type two diabetes, and cardiovascular disease. Reducing levels of CRP with 
inflammatory modulating compounds, like curcumin, may be beneficial over the long term.31-33  
Athletes who participate in CrossFit exercise multiple times per week may be in prolonged states 
of inflammation from frequent and intense physical activity. This graduate student research study 
aimed to investigate the effects of oral curcumin and bioperine supplementation on CRP levels in 
CrossFit athletes. To our knowledge, a study involving this intervention amongst CrossFit 
athletes had not yet been performed. We hypothesized that after four weeks of oral 
supplementation of 2 grams of curcumin with 20 μg of bioperine, we would observe significantly 
lowered CRP levels in CrossFit athletes.  
Methods 
 
Participants 
 
Twenty healthy, non-pregnant, non-smoking participants were recruited from the CrossFit South 
Redlands gym in the Inland Empire region of southern California. Upon permission from the 
CrossFit gym’s owner, researchers recruited in-person by setting up a table in the entryway of 
the CrossFit gym to inform the athletes about the study. Recruitment took place through brief in-
person informative meetings prior to scheduled workout sessions at the CrossFit gym, through 
word of mouth, and by posting flyers in the gym. Individuals interested in participating were 
screened for inclusion and exclusion criteria. Participants included in the study were healthy 
adults between the ages of 18-45 years who had participated in CrossFit exercise at least two 
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times per week for at least three months prior to the start of the study. Potential participants were 
excluded for pregnancy, cardiovascular disease, diabetes, arthritis, gingivitis, history of cancer 
other than small sections of skin, cigarette smoking and/or tobacco use, use of any blood 
thinning medications, and use of turmeric and/or other herbal supplementation within the last 30 
days. 
All volunteers were first informed of the study objectives and methods. Upon agreeing to 
participate in the study, participants signed an informed consent and completed an additional 
form to provide demographic information. The requested information included height, weight, 
gender, marital status, education level, and age. All methods and procedures were approved by 
the Institutional Review Board of Loma Linda University.  
Compliance  
For each day of the study, participants were asked to record supplement intake on a compliance 
log. Participants were instructed to take missed pills with the next day’s pills (up to eight at a 
time, with food) if a day of supplementation was missed. Participants were asked to indicate, 
“eight pills taken” in the designated notes section on the day the pills were consumed. 
Participants were asked to record all over-the-counter and prescription medications, as well as 
the dose of medication, taken during the duration of the study on their supplementation 
compliance log. Participants were also instructed to record any immunizations received during 
the study on the compliance log, denoting the type of immunization and the date on which it was 
received.  
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Questionnaires 
On the first day of testing, participants were asked to complete a demographics form. This form 
was used to collect information such as name, participant identification, height, weight, contact 
information, age, gender, highest level of completed education, ethnicity, marital status, sexual 
activity, and fluid intake. On both testing days, participants were given a Perceived Stress Scale 
form to indicate their current level of psychogenic stress. They were also asked to complete a 
Testing Day Questionnaire, in which they were asked to provide information regarding fluid 
intake, food intake, over-the-counter and prescription medications, sexual activity, and any other 
information the participants felt may impact their test results.  
Supplementation 
The supplement used for this study was obtained from Pure Encapsulations, Inc., The dosage 
instructed for daily consumption was four pills containing a total of 2 grams of curcumin with 20 
μg of bioperine and 10 mg of ascorbyl palmitate (a vitamin C ester with antiscorbutic activity). 
The supplement used for this study contained bioperine to increase the bioavailability of 
curcumin. The ascorbyl palmitate present in the supplement used for this study acted primarily as 
a preservative rather than an exogenous antioxidant. Although some research has shown that 
vitamin C supplementation has beneficial effects on CRP levels,35 the maximum dosage of 
vitamin C from the supplement used for this study was only 4-8% of the dose used in studies 
shown to reduce CRP levels.  
High Sensitivity C Reactive Protein (hsCRP) Testing 
 
All hsCRP tests were performed at the designated CrossFit gym by qualified professionals. 
Participants were informed about the procedure of collecting the blood for measuring hsCRP 
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levels. Care was taken so that each participant was tested near the same time on each day their 
hsCRP level was measured. The kit box equilibrated at room temperature for a minimum of 10 
minutes to allow material to warm up to room temperature before use. 
Assay procedure and Sample Collection (Pre- and Post- Supplementation): 
 
 Diazyme hsCRP Test Kit box was used to analyze capillary blood specimen for hsCRP. The 
Kit provided a Radio Frequency ID (RFID) card which was inserted into the SMART 700-
340 device prior to analysis. 
 
 Prior to acquiring and running participant samples the Research Assistant ran the BioRad 
developed Diazyme controls. 
 
 One reaction cuvette and one reagent cap from the kit box was used for each participant 
sample. Each participant had two baseline samples and two post-intervention samples.  
 
 Proper standard precautions were taken to maintain safety and hygiene. Disposable nitrile 
gloves were worn by the phlebotomist while collecting blood samples. 
 
 The participants were asked to rub their hands together to improve blood circulation. Gentle 
pressure was applied circumferentially to the mid-finger before the fingerstick to encourage 
better blood flow. The phlebotomist continued to apply intermittent, gentle, circumferential 
pressure to the mid-finger immediately after the fingerstick and during the blood acquisition 
to prevent interstitial fluid concentrated at the tips of the fingers. 
 
 The participant’s non-dominant hand 4th or 5th digit was cleaned with a swab saturated with 
70% isopropyl alcohol. The cleaned finger dried completely before the fingerstick was 
performed.  
 
 An Accu-Check® Safe-T-Pro Plus, sterile, single-use lancet of 1.8mm depth, 23 gauge/0.63 
mm width was used. The phlebotomists grasped the lancet between their dominant thumb 
and forefinger and activated the lancet with their thumb. During the fingerstick the lancet 
was held perpendicular to the fingertip with firm and even pressure. Immediately after the 
lancet was activated and discarded in the sharps container, the first drop of blood was cleaned 
with a sterile cotton swab to minimize collection of interstitial fluid. 20 µL of capillary blood 
was collected using two EDTA capillaries. 
 
 The participant had a bandage applied to the lanced finger after 40 µL of blood was 
collected.  
 
 Each 20µl blood sample (40 µl total) was then added into two reaction cuvettes. 
 
 Specimens were labeled with the subject ID number. 
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 A reagent cap was placed on the top of the reaction cuvettes and snapped into place. 
 
 Specimens were stored at 23C until analyzed in the LLU Clinical Molecular 
Psychoneuroimmunology Lab within five hours. 
 
 The participant’s ID number was entered in the Diazyme SMART analyzer. 
 
 The capped reaction cuvettes were inserted into the cuvette holder on the door of the 
SMART analyzer. Prior to its insertion into the instrument, the cuvette was examined for 
even blood mixture without bubbles and wiped with lint a free Kimwipe or similar 
nonabrasive cloth to ensure the cuvette surface was clean. 
 
 The hsCRP assay was performed according to manufacturer guidelines. Specimens were 
assayed one at a time. 
 
 The results were stored in the device as well as recorded by a researcher in a secure password 
locked Excel spreadsheet.  
 
Procedure 
This study was a non-randomized controlled trial. Following completion of the IRB consent form 
and signed authorization for the use of protected health information, participants were instructed 
to return the following week for the first day of CRP testing. All recruited participants received a 
follow-up email and phone call at least 48 hours prior to the first day of testing to remind them of 
the upcoming study procedures. On the first day of testing, participants met at the CrossFit South 
Redland’s gym. Upon arrival, participants filled out the designated paperwork (Demographics 
form, Bill of Rights, Testing Day Questionnaire and Perceived Stress Scale), body weights were 
recorded, and baseline measurements of CRP were collected by a single fingerstick. Once 
baseline measurements were taken, participants received verbal instructions, a Compliance Log 
with written instructions and contact information, and a 28-day supply of supplementation.  
Participants were instructed to consume the assigned product daily for four weeks. 
Instructions provided to the participants indicated that four pills should be taken per day, at about 
the same time each day, and preferably with the participant’s first meal of the day. In addition, 
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participants were instructed to maintain their previous dietary and exercise practices during 
participation. 
All participants received an email or text message 48 hours prior to the second day of 
testing to remind them of the upcoming study procedures. On the final day of supplementation, 
16 of the 20 recruited participants returned to the CrossFit gym for the second day of CRP 
testing. Upon arrival, all participants completed the designated paperwork (Testing Day 
Questionnaire and Perceived Stress Scale) and submitted their finished Compliance Logs. 
Additionally, weights were taken on the same scale used for the first day of CRP testing and 
post-supplementation measurements of CRP were collected by a single fingerstick.  
Data Analysis 
Collected data was evaluated using SPSS version 24 software using a paired t-
test.Frequencies, mean and standard deviation were calculated for the demographic information 
collected from the participants. 
Results  
Of 20 participants who were recruited, 16 completed the study in its entirety. Post-
supplementation data was not collected for four participants who were lost to follow-up. 
Analysis was conducted using pre- and post- supplementation data collected for 16 participants 
(nine males (56.3%) and seven females (43.8%)). Participant demographic data is provided in 
Table 1.  
CrossFit athletes were instructed to have their initial fingerstick blood draw prior to their 
work out on the first day of data collection. Twelve participants’ pre-supplementation fingerstick 
blood samples were collected prior to their workout that day. Due to scheduling constraints, four 
participants were unable to provide fingerstick blood draw samples before working out and 
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therefore had their baseline CRP data collected after their workout. To control for this variability, 
on the second day of data collection, the same athletes provided post-supplementation fingerstick 
blood draw samples after they worked out. 
BMI did not differ between the baseline and the follow-up 28 days later (p=.50), during 
which time the participants were instructed to continue their usual diet and exercise patterns. 
Similarly, perceived stress did not differ between the baseline and follow-up measures (p=.25). 
To assess the effect of curcumin and bioperine supplementation, we examined the inflammatory 
marker hsCRP using a Point of Care hsCRP assay. As summarized in Table 2, the mean 
difference in CRP at follow-up decreased by 0.26 +/- 2.27 mg/L; however, this change was not 
statistically significant (p=.65).  
Overall, five participants (31.3%) showed an increase in CRP at follow-up, five 
participants (31.3%) showed a decrease in CRP, and six participants (37.5%) showed no 
observable change in CRP at follow-up. A SMART 700-340 point of care device was used to 
analyze CRP values. The absence of measurable changes for six participants is relative to the 
decreased sensitivity of the POC assay, where the instrument cannot measure CRP levels <0.50 
mg/L. “No change” is used to identify individuals who had CRP levels below the sensitivity 
threshold for both pre- and post-supplementation measurements. Individual differences between 
each participant’s baseline and post-supplementation CRP levels are shown in Figure 1. 
The change in CRP was tested separately for the pre- and post-exercise measurement 
groups. Participants in the post-exercise measurement group had a mean CRP difference of +.90 
+/- 0.87 mg/L at follow-up. The observed increase was not statistically significant (p=.25). 
Participants in the pre-exercise measurement group had a mean CRP difference of -0.65 +/- 2.48 
mg/L at follow-up. This observed decrease was not statistically significant (p=.25). Moreover, 
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the variability in CRP difference for the pre-exercise group was largely due to one participant’s 
CRP that had decreased by 7.97 mg/L at follow-up. A non-parametric test confirmed this 
participant’s individual measurements did not change the overall results.  
Discussion 
 
The current study did not reveal a statistically significant difference in CRP level in CrossFit 
athletes after a 28-day oral curcumin and bioperine supplementation.Our study participants’ low 
baseline CRP levels support previous research, which suggests that while acute exercise has been 
shown to transiently increase CRP levels in trained athletes, there is an inverse relationship 
between elevated CRP and routine strenuous exercise.36 It is likely that our study sample has 
acclimated to exercise-induced stress by regularly participating in CrossFit exercise. In turn, half 
of participants demonstrated no measurable change in CRP from pre- versus post-
supplementation. These participants each had baseline and post-supplementation CRP 
measurements <0.50 mg/L. Scores that were below the POC instrument’s sensitivity threshold of 
<0.50 mg/L displayed a result of <0.50 mg/L. Therefore, differences in pre- and post-
supplementation CRP levels could not be quantified in individual results with lower than the 
instrument sensitivity results. It is unlikely that CRP levels for these individuals remained 
unchanged, but with the instrumentation utilized positive and/or negative changes could not be 
quantified. 
One participant’s post-supplementation CRP level was drastically lower than his baseline 
measurement, which was 941% higher than the mean baseline CRP of other participants. A non-
parametric test confirmed that this participant’s individual measurements did not change the 
overall results. Data collected throughout the study did not provide a clear explanation for his 
high baseline CRP as an outlier; however, there are several speculations that can be made 
 11
regarding explanations for his baseline level. Some previous studies have shown great variance 
in baseline CRP levels for trained athletes participating in strenuous exercise, ranging from 0.2-
13.9 mg/L.36 
A primary strength of the current study is its novelty. To our knowledge there are no 
previous studies evaluating the effects of curcumin and bioperine supplementation on CRP in 
CrossFit athletes. The study design was strengthened in that it attempted to control for other 
factors that could influence CRP such as stress, change in body mass index, and pre-existing 
medical conditions. The supplementation period of 28-days mirrors the average menstrual cycle 
length for women, controlling for CRP differences associated with menstruation. Additionally, 
gender was relatively evenly distributed in the study’s sample. Furthermore, pre- and post-
supplementation CRP levels were measured within two hours of each other on respective testing 
days.  
The study is limited by the low sensitivity of the point of care device used to analyze 
hsCRP assays. Of the 16 participants who provided CRP samples, only 10 supplied measurable 
data, thus limiting the statistical power of our analysis. This acted as a limitation to our already 
small pilot study sample size. While BMI did not significantly change and general eating pattern 
information was collected, in-depth food-frequency questionnaires were not conducted. Lastly, 
information regarding exercise within 24-48 hours of data collection was not assessed. 
Acquisition of this information would have been beneficial since CRP values may have been 
impacted by exercise performed 24-48 hours prior to baseline and/or follow-up data collection.  
Future research should use laser nephelometry to assess hsCRP levels, which would 
lower the sensitivity level to as much as 0.04 mg/L. The use of an ultra-sensitive instrument 
would provide more specific levels and prevent the loss of measurable data. Additionally, future 
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research should consider using other inflammatory markers such as pre-cursors to CRP. These 
include IL-6 and TNF-alpha, both of which are the first inflammatory markers produced and 
released by skeletal muscles during exercise. Prospective research should also investigate the 
effects of curcumin supplementation on CrossFit athletes with both shorter and longer study 
durations. Other areas of interest include the effects of curcumin supplementation on athletes 
versus non-athletes, the effects of varied amounts of curcumin dosages, and the differences 
between supplementation daily versus supplementation throughout the day. 
Conclusion  
CrossFit athletes who have been participating in CrossFit activities on a regular basis appear to 
be more likely to have low CRP levels. In the current study, it is observed that a 28-day 
supplementation of curcumin and bioperine has reduced overall CRP levels in CrossFit athletes, 
however, the reduction in CRP was not statistically significant. Previous research supports the 
use of curcumin as an anti-inflammatory agent; however, its impact on CRP levels in CrossFit 
athletes warrants additional investigation. We conclude that the effects of curcumin on CRP in 
CrossFit athletes needs to be explored further with observations using larger sample sizes that are 
controlled for exercise type, duration, and intensity, in which CRP values are analyzed by an 
ultra-sensitive testing device. 
 
Acknowledgments 
Our research team would like to thank the participants who took part in our study. We would 
also like to express our appreciation to Loma Linda University and CrossFit South Redlands for 
the use of their facilities. Lastly, we would like to thank the following individuals for their 
ongoing assistance, insight, and guidance in the development and successful execution of our 
 13
research study: Gurinder Bains, PhD, Lee Berk, DrPH, Kristin Bruhjell, B.S., Cory Gheen, M.S., 
RDN, Jeje Noval, PhD, RDN and Grenith Zimmerman, PhD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 14
References 
1. Sallis R. A Drug Called Exercise: Why You Should Take and Prescribe It. Lecture presented 
at Loma Linda University; February 16, 2016; Loma Linda, CA. 
 
2. McFarlin BK, Venable AS, Henning AL, et al. Reduced inflammatory and muscle damage 
biomarkers following oral supplementation with bioavailable curcumin. BBA Clin. 
2016;5:72-78. doi:10.1016/j.bbacli.2016.02.003. 
 
3. Nicol LM, Rowlands DS, Fazakerly R, Kellett J. Curcumin supplementation likely attenuates 
delayed onset muscle soreness (DOMS). Eur J Appl Physiol. 2015;115:1769-1777. 
doi:10.1007/s00421-015-3152-6. 
 
4. Drobnic F, Riera J, Appendino G, et al. Reduction of delayed onset muscle soreness by a 
novel curcumin delivery system (Meriva®): a randomized, placebo-controlled trial. J Int Soc 
Sports Nutr. 2014;11(1):1-10. doi:10.1186/1550-2783-11-31. 
 
5. Nehlsen-Cannarella SL, Fagoaga OR, Nieman DC, et al. Carbohydrate and the cytokine 
response to 2.5 h of running. J Appl Physiol. 1997; 82:1662–1667.  
 
6. Gleeson M, Blannin AK, Walsh NP, Bishop NC, Clark AM. Effect of low and high 
carbohydrate diets on the plasma glutamine and circulating leukocyte responses to exercise. 
Int J Sport Nutr Exerc Metab. 1998;8:49–59.  
 
7. Mitchell JB, Pizza FX, Paquet A, Davis BJ, Forrest MB, Braun WA. Influence of 
carbohydrate status on immune responses before and after endurance exercise. J Appl 
Physiol. 1998; 84:1917–1925.  
 
8. Nieman DC. Immunonutrition support for athletes [review] Nutr Rev. 2008; 66(6):310–3220. 
doi: 10.1111/j.1753-4887.2008.00038.x.  
 
9. Walsh NP, Gleeson M, Pyne DB, et al. Position statement part two: maintaining immune 
health. Exerc Immunol Rev. 2011; 17:64–103.  
 
10. Anand P, Sherin TG, Kunnumakkara AB, et al. Biological activities of curcumin and its 
analogues & congeners made by man and mother nature. Biochem Pharmacol. 
2008;76:1590–1611. doi: 10.1016/j.bcp.2008.08.008.  
 
11. Pfeiffer E, Hoehle SI, Walch SG, Riess A, Solyom AM, Metzler M. Curcuminoids form 
reactive glucuronides in vitro. J Agric Food Chem. 2007; 55:538–544. doi: 
10.1021/jf0623283.  
 
12. Somparn P, Phisalaphong C, Nakornchai S, Unchern S, Phumala N, Morales NP. 
Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated 
derivatives. Biol Pharm Bull. 2007; 1:74–78. doi: 10.1248/bpb.30.74.  
 
 15
13. Turmeric. University of Maryland Medical Center. 
http://umm.edu/health/medical/altmed/herb/ turmeric. Published June 26, 2014. Accessed 
April 8, 2016.  
 
14. Ghosh S, Banerjee S, Sil PC. The beneficial role of curcumin on inflammation, diabetes and 
neurodegenerative disease: a recent update. Food and Chemical Toxicology 2015; 83:111–
124. doi:10.1016/j.fct.2015.05.022.  
 
15. Shehzad A, Rehman G, Lee YS. Curcumin in inflammatory diseases. BioFactors 
2012;39(1):69–77. doi:10.1002/biof.1066.  
 
16. Sikora E, Scapagnini G, Barbagallo M. Curcumin, inflammation, ageing and age-related 
diseases. Immun Ageing Immunity & Ageing 2010;7(1):1. doi:10.1186/1742-4933-7-1.  
 
17. Prasad S, Tyagi AK, Aggarwal BB. Recent developments in delivery, bioavailability, 
absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer Res 
Treat Cancer Research and Treatment. 2014;46(1):2-18. doi:10.4143/crt.2014.46.1.2.  
 
18. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas P. Influence of piperine on the 
pharmacokinetics of curcumin in animals and human volunteers. Planta Med Planta 
Medica. 1998;64(04):353-356. doi:10.1055/s-2006-957450.  
 
19. Patil VM, Das S, Balasubramanian K. Quantum chemical and docking insights into   
bioavailability enhancement of curcumin by piperine in pepper. J Phys Chem 
A.2016;120(20):3643-3653. doi:10.1021/acs.jpca.6b01434. 
 
20. Davis JM, Murph, EA, Carmichael MD, et al. Curcumin effects on inflammation and 
performance recovery following eccentric exercise-induced muscle damage. American 
Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2007; 292: 
R2168-R2173. doi:10.1152/ajpregu.00858.2006. 
 
21. Aggarwal BB, Harikumar KB. Potential Therapeutic Effects of curcumin, the anti-
inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, 
autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2008; 41(1):40–59. doi: 
10.1016/j.biocel.2008.06.010.  
 
22. Kawanishi N, Kato K, Takahashi M, et al. Curcumin attenuates oxidative stress following 
downhill running-induced muscle damage. Biochem Biophys Res Commun. 2013; 22:573–78. 
doi: 10.1016/j.bbrc.2013.10.119. 
 
 
23. Akazawa N, Choi Y, Miyakia A,et al. Curcumin ingestion and exercise training improve 
vascular endothelial function in postmenopausal women. Nutr Res. 2012; 32(10):795–799. 
doi: 10.1016/j.nutres.2012.09.002. 
 
 16
24. McFarlin BK, Venable AS, Henning AL, et al. Reduced inflammatory and muscle damage 
biomarkers following oral supplementation with bioavailable curcumin. BBA Clin. 
2016;5:72-78. doi:10.1016/j.bbacli.2016.02.003. 
 
25. Nicol LM, Rowlands DS, Fazakerly R, Kellett J. Curcumin supplementation likely attenuates 
delayed onset muscle soreness (DOMS). Eur J Appl Physiol. 2015;115:1769-1777. 
doi:10.1007/s00421-015-3152-6. 
 
26. Drobnic F, Riera J, Appendino G, et al. Reduction of delayed onset muscle soreness by a 
novel curcumin delivery system (Meriva®): a randomized, placebo-controlled trial. J Int Soc 
Sports Nutr. 2014;11(1):1-10. doi:10.1186/1550-2783-11-31. 
 
27. Martin RCG, Aiyer HS, Malik D, Li Y. Effect on pro-inflammatory and antioxidant genes 
and bioavailable distribution of whole turmeric vs curcumin: similar root but different 
effects. Food Chem Toxicol. 2012;50(2):227-231. doi:10.1016/j.fct.2011.10.070. 
 
28. Shephard R. Pentraxin3 and high-sensitive C-reactive protein are independent inflammatory 
markers released during high-intensity exercise. Yearbook of Sports Medicine 2011; 
2011:148–149. doi:10.1016/j.yspm.2011.02.006.  
 
29. Michigan A, Johnson TV, Master VA. Review of the relationship between c-reactive protein 
and exercise. Mol Diag Ther Molecular Diagnosis & Therapy 2011;15(5):265-275. 
doi:10.1007/bf03256418.  
 
30. Nieman D. Exercise without weight loss does not reduce c-reactive protein: the INFLAME 
Study. Yearbook of Sports Medicine 2011. 2011:142–144. doi:10.1016/j.yspm.2011.03.033.  
 
31. Torgeir W, Haugnes H, Kjekshus J, et al. 599 C-reactive protein; a potential marker of 
second cancer and cardiovascular disease in testicular cancer survivors? European Journal 
of Cancer Supplements 2010;8(5):152-153. doi:10.1016/s1359-6349(10)71400-2.  
 
32. Nesto R. C-reactive protein, its role in inflammation, type 2 diabetes and cardiovascular 
disease, and the effects of insulin-sensitizing intervention with thiazolidinediones. Diabetic 
Medicine Diabet Med. 2004;21(8):810–817. doi:10.1111/j.1464-5491.2004.01296.x.  
 
33. Tabak AG, Kivimaki M, Brunner EJ, et al. Changes in C-reactive protein levels before type 
2 diabetes and cardiovascular death: the Whitehall II study. European Journal of 
Endocrinology. 2010;163(1):89–95. doi:10.1530/eje-10-0277.  
 
34. Pure Encapsulation, Inc. 490 Boston Post Rood, sudbary, MA , 01776. 
 
35. Block G, Jensen CD, Dalvi TB, et al. Vitamin C treatment reduces elevated C-reactive 
protein. Fre Radic Biol Med. 2009;46(1):70-77. doi: 10.1016/j.freeradbiomed.2008.09.030. 
 
 
 17
36. Kasapis, C, Thompson PD. The effects of physical activity on serum C-reactive protein and 
inflammatory markers: a systematic review. J Am Coll Cardiol. 2005;45(10):1563-1569. 
doi: 10.1016/j.jacc.2004.12.07 
 
  1
Bailey Franzen, Cassandra Greenawalt & Sloan Vlahos 
Research Report 
May 15, 2017 
 
The effects of oral curcumin and bioperine supplementation on C-reactive protein in 
CrossFit athletes 
 
Table 1. Baseline Demographic Information for 16 Participants prior to 
28-Week Oral Curcumin and Bioperine Supplementation  
Variable n % 
Gender 
Female 7 43.8 
Male 9 56.3 
Education Level 
Bachelor's degree 5 31.3 
Master's degree 3 18.8 
Some college credit, no degree 3 18.8 
Doctorate  2 12.5 
Trade/technical/vocational training 2 12.5 
High school graduate, diploma, or equivalent 1 6.3 
Ethnicity 
White 10 62.5 
Hispanic or Latino 2 12.5 
Asian / Pacific Islander 1 6.3 
White & Black or African American 1 6.3 
White & Pacific Islander 1 6.3 
Unspecified 1 6.3 
Age Group 
18-23 2 12.5 
24-29 3 18.8 
30-35 5 31.3 
36-41 3 18.8 
42-45 3 18.8 
Marital Status 
Divorced  1 6.3 
Married 1 6.3 
Married or domestic partnership 8 50.0 
Separated 1 6.3 
Single - never married 5 31.3 
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*Paired t-test 
 
 
 
 
Figure 1. Individual difference in participant baseline CRP and post-
supplementation CRP values following 28-day curcumin supplementation.  
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Table 2. BMI, Perceived Stress Score, and CRP for 16 Participants pre- and post- 28-Day Oral 
Curcumin and Bioperine Supplementation 
 Pre supplementation Post-supplementation Difference P* 
BMI 
Perceived 
Stress 
Mean(SD) Mean(SD) Mean(SD)  
 
26.18(2.89) 
10.06(6.28) 
1.26(2.04) 
 
26.08(2.82) 
9.00(6.14) 
1.00(0.94) 
 
0.11(0.61) 
1.06(3.57) 
0.26(2.27) 
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